Increased prevalence of ANA and Anti-SSA in African American rheumatoid arthritis patients is not associated with increased serum chemokine concentrations
Journal Title: International Journal of Clinical Rheumatology - Year 2017, Vol 12, Issue 5
Abstract
Background: African American (AA) rheumatoid arthritis (RA) patients have increased disease activity compared to Caucasian (CAU) RA patients. Serum chemokines, such as CXCL10, are increased in RA patients and may function as markers of disease activity. The aim of this study was to compare autoantibody seropositivity in AA and CAU RA patients and analyze the link between antibody positivity and serum chemokine concentration. Methods and Findings: 93 AA RA patients and 93 CAU patients from the University of Pittsburgh cohort of RA patients were matched using a propensity model with race as the outcome and age, gender, body mass index (BMI), disease duration, anti-tumor necrosis factor (TNF) use, rheumatoid factor (RF) positivity, and cyclic citrullinated peptide (CCP) positivity as the predictor variables in a logistic regression. Plasma from the matched subjects was analyzed for autoantibodies including antinuclear antibody (ANA), anti-Sjogren's syndrome-related Antigen A (SSA), and anti-Sjogren's syndromerelated Antigen B (SSB). To evaluate differences in serum chemokine concentrations, anti-SSA positive samples were matched with anti-SSA negative samples for age, gender, disease duration, RF positivity, and CCP positivity using a propensity model. CXCL10 was measured using an ELISA assay. Anti-SSA was more prevalent in AA RA patients compared to CAU RA patients (11.70% vs. 3.23%; p=0.02). ANA was more prevalent in AA RA patients (21.28% vs. 10.75%; p=0.04). A total of 14 patients (7.57%) were anti-SSA positive. Anti-SSA positivity was not associated with increased serum CXCL10 levels compared to the anti-SSA negative group. RF positivity was associated with an increased serum CXCL10 concentration compared to the RF negative group (253.14 vs 153.46 pg/ml). Conclusions: AA RA patients have an increased prevalence of anti-SSA and ANA compared to CAU RA patients, which may be contributing to the increased disease activity seen in this population via a mechanism outside of the CXCL10 chemokine pathway.
Authors and Affiliations
Tyler J. Sevco, Doug P. Landsittel, Chengli Shen, Larry W Moreland
Keywords
Related Articles
- EP ID EP603708
- DOI -
- Views 49
- Downloads 0
Influence of single nucleotide polymorphisms on the efficacy of platelet-rich plasma in the treatment of injuries
Tissue repair in musculoskeletal injuries is often a slow and sometimes incomplete process. Musculoskeletal injuries have a great impact on athletes’ especially elite athletes – and a rapid recovery of full efficiency an...
Young girl diagnosed with chronic recurrent multi-focal osteomyelitis
Chronic Recurrent Multi-focal Osteomyelitis is a rare form of inflammatory disorder diagnosed after exclusion of malignancy, and infection. It is rare due to obscure knowledge of physicians regarding this disease and lac...
Predictors of quality of life improvement following peer mentoring in AfricanAmerican women with systemic lupus erythematosus (sle)
Background: Systemic lupus erythematosus is a complex autoimmune disorder with heterogeneous presentation. Behavioral interventions have had mixed effects among this population, particularly among African American women,...
Epileptic seizure: An unusual presentation of takayasu arteritis
Background: Takayasu arteritis is a vasculitic disease involving major arteries. It commonly presented with constitutional symptoms. Neurological manifestations such as headache, transient ischemic attack, stroke, vertig...
Relapsing IgG4-related orbital inflammatory pseudotumor after achieving success with rituximab
IgG4-related disease (IgG4-RD) is a disease of fibroinflammatory with infiltration of IgG4-positive plasma cells. The lesions show focal or diffuse nodular formations in one or multiple organs; due to the infiltration of...